Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
N6AMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CYB5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PTCD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCAIM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POGLUT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNGTT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MED7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNGB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMX1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAS7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAOX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C12orf43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTCH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on